Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Arrhythmia|February 14, 2025
Effectiveness of upgrade left bundle branch area pacing for right ventricular pacing-induced cardiomyopathy: Extra QRS shortening mattersHao Huang, Xiaofeng Li, Tianxin Long, et al.
Heart Rhythm O2|February 16, 2026
Myocardial fibrosis predicts sudden cardiac death in patients with hypertrophic cardiomyopathy after cardiac electronic device implantation: Insights from cardiovascular magnetic resonance imagingBingqi Fu, Xinqiao Lian, Hao Huang, et al.
Clinical Biochemistry|April 14, 2025
Plasma trimethylamine levels predict adverse cardiovascular events in sudden cardiac arrest Survivors: A prospective cohort studyHao Huang, Sijing Cheng, Tianxin Long, et al.
Acta Diabetologica|June 19, 2024
Association between triglyceride-glucose index and the risk of heart failure hospitalization in older diabetic patients received right ventricular pacing: a retrospective cohort studyBingqi Fu, Yu Yu, Sijing Cheng, et al.
European Journal of Preventive Cardiology|February 12, 2025
Sex Differences in Cardiovascular-Kidney-Metabolic Risk Factors Associated with Degenerative Valvular Heart DiseaseCheng Yang, Ziang Li, Yonggang Sui, et al.
Innovation in Aging|August 12, 2024
Physical Frailty and the Risk of Degenerative Valvular Heart DiseaseXinli Guo, Ziang Li, Tianxin Long, et al.
British Journal of Sports Medicine|March 12, 2025
Wearable device-measured physical activity and incident cardiovascular disease in cancer survivorsChengqing Jiang, Ziang Li, Bo Guo, et al.
European Heart Journal|July 2, 2024
Wearable device-measured moderate to vigorous physical activity and risk of degenerative aortic valve stenosisZiang Li, Sijing Cheng, Bo Guo, et al.
Frontiers in Cardiovascular Medicine|March 17, 2022
Loss of m<sup>6</sup>A Methyltransferase METTL5 Promotes Cardiac Hypertrophy Through Epitranscriptomic Control of SUZ12 ExpressionYanchuang Han, Tailai Du, Siyao Guo, et al.
Frontiers in Cardiovascular Medicine|April 4, 2022
Cardiac ISL1-Interacting Protein, a Cardioprotective Factor, Inhibits the Transition From Cardiac Hypertrophy to Heart FailureYouchen Yan, Tianxin Long, Qiao Su, et al.
Pageof 3